ZA865975B - Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues - Google Patents
Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residuesInfo
- Publication number
- ZA865975B ZA865975B ZA865975A ZA865975A ZA865975B ZA 865975 B ZA865975 B ZA 865975B ZA 865975 A ZA865975 A ZA 865975A ZA 865975 A ZA865975 A ZA 865975A ZA 865975 B ZA865975 B ZA 865975B
- Authority
- ZA
- South Africa
- Prior art keywords
- disubstituted
- amino
- acid residues
- renin inhibitors
- hydroxypentanoic acid
- Prior art date
Links
- -1 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues Chemical group 0.000 title 1
- 239000002461 renin inhibitor Substances 0.000 title 1
- 229940086526 renin-inhibitors Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/86—Renin inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76416885A | 1985-08-09 | 1985-08-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA865975B true ZA865975B (en) | 1988-03-30 |
Family
ID=25069874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA865975A ZA865975B (en) | 1985-08-09 | 1986-08-08 | Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US4948913A (de) |
| DD (1) | DD257391A5 (de) |
| ZA (1) | ZA865975B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5286897A (en) * | 1990-12-28 | 1994-02-15 | Ajinomoto Co., Inc. | N-t-butyloxycarbonyl-3-cyclohexyl-L-alanine methyl ester in crystalline form |
| EP0493087B1 (de) * | 1990-12-28 | 1996-03-13 | Ajinomoto Co., Inc. | Verfahren zur Kristallisierung von N-t-Butoxycarbonyl-3-cyclohexyl-L-alaninmethylester |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4487963A (en) * | 1983-01-03 | 1984-12-11 | Merck & Co., Inc. | Enantioselective synthesis of 4-amino-3-hydroxy-2,4-(disubstituted)pentanoic acid |
| FR2590894B1 (fr) * | 1985-12-02 | 1988-09-02 | Sanofi Sa | Derives d'acide amino-4 butanoique, leur procede de preparation et leur utilisation |
| JPH0772167B2 (ja) * | 1986-09-04 | 1995-08-02 | サントリー株式会社 | 4―アミノ―3―ヒドロキシ酪酸誘導体の製法 |
-
1986
- 1986-08-08 ZA ZA865975A patent/ZA865975B/xx unknown
- 1986-08-08 DD DD86293529A patent/DD257391A5/de not_active IP Right Cessation
-
1987
- 1987-11-02 US US07/336,697 patent/US4948913A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US4948913A (en) | 1990-08-14 |
| DD257391A5 (de) | 1988-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2184730B (en) | Ureido renin inhibitors | |
| IL88273A0 (en) | Renin inhibitors | |
| GR862276B (en) | Improved process for tetrafluorobenzoic acid | |
| GB8322414D0 (en) | Renin inhibitors | |
| GR871770B (en) | Renin inhibitors | |
| AU7079887A (en) | N, s containing corrosion inhibitors | |
| GR862032B (en) | Dopamine-b-hydroxylase inhibitors | |
| PH24655A (en) | Renin inhibitors iii | |
| PH21776A (en) | Dopamine-b-hydroxylase inhibitors | |
| SG39791G (en) | Corrosion inhibitors | |
| ZA866061B (en) | Process for tetrafluorobenzoic acid | |
| ZA865975B (en) | Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues | |
| GB2173183B (en) | Scale inhibitors | |
| ZA879030B (en) | Renin inhibitors iii | |
| ZA868234B (en) | Dopamine-beta-hydroxylase inhibitors | |
| YU115086A (en) | Process for obtaining new benzamides | |
| PT81973A (en) | Dopamine-beta-hydroxylase inhibitors | |
| IE873186L (en) | Renin inhibitors iv | |
| IE873034L (en) | Renin inhibitors containing phenylalanyl-histidine¹replacements | |
| HUT42704A (en) | Anhydrous agent for sun-bathing | |
| GB8606284D0 (en) | Scale inhibitors | |
| CS871386A1 (en) | Corrosion inhibitor for acid atmospheres | |
| ZA888239B (en) | Renin inhibitors | |
| IE873185L (en) | Renin inhibitors iii | |
| GB8527336D0 (en) | Acid gas removal |